Sequential Pembrolizumab and AVD is Highly Effective at any PD-L1 Expression Level in Untreated Hodgkin Lymphoma

Overview of attention for article published in Blood Advances, June 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 3 news outlets
twitter: 23 X users

reddit: 1 Redditor

Readers on

mendeley: 22 Mendeley

So far, Altmetric has seen 25 X posts from 23 X users, with an upper bound of 29,583 followers.

Sequential checkpoint inhibitor and AVD are highly effective in untreated Hodgkins lymphoma, getting an overall survival rate of 100% at the median followup of 22.5 months, supported by complete metabolic response on FDG PET imaging. https://t.co/6MAXJ1…

RT @smbenlazar: >>> Sequential Pembrolizumab and AVD is Highly Effective at any PD-L1 Expression Level in Untreated Hodgkin Lymphoma. >>> 1…

RT @LymphomaEx: Secuencial: Pembro x 3 AVD x 4-6 was RC post pembro: 36.7% R casi completa: 26.7% RC post 2 AVD: 100% ➡️curvas SLP y SG pla…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 21 additional X posts.